Glutamine breakdown in rapidly dividing cells: Waste or investment?

BioEssays

Volumn 26, Issue 7, 2004, Pages 778-785

  Aledo, J Carlos ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; NITROGEN; ADENOSINE TRIPHOSPHATE; AMINO ACID; AMINO ACID TRANSPORTER;

BIOENERGY; CELL DIVISION; CELL PROLIFERATION; ENERGY; PROCESS MODEL; PROTEIN DEGRADATION; REVIEW; TUMOR CELL; ANIMAL; ARTICLE; CELL; CYTOLOGY; HUMAN; HYDROLYSIS; METABOLISM; THERMODYNAMICS; TRANSPORT AT THE CELLULAR LEVEL;

ADENOSINE TRIPHOSPHATE; AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; CELLS; GLUTAMINE; HUMANS; HYDROLYSIS; THERMODYNAMICS;

EID: 3342954730     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20063     Document Type: Review

References (71)

1. Carrascosa JM, Martínez P, Núñez de Castro I. 1984. Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascetic tumor cells. Cancer Res 44:3831-3835.
2. Moreadith RW, Lehninger AL. 1984. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. J Biol Chem 259:6215-6221.
3. Newsholme EA, Crabtree B, Ardawi MSM. 1985. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Reports 5:393-400.
4. Medina MA, Sánchez-Jiménez F, Márquez J, Quesada AR, Núñez de Castro I. 1992. Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 113:1-15.
5. Molina M, Segura JA, Aledo JC, Medina MA, Núñez de Castro I, et al. 1995. Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane. Biochem J 308:629-633.
6. Aledo JC, de Pedro E, Gómez-Fabre PM, Núñez de Castro I, Márquez J. 1997. Submitochondrial localization and membrane topography of Ehrlich ascitic tumour cell glutaminase. Biochim Biophys Acta 1323:173-184.
7. Aledo JC, Segura JA, Medina MA, Alonzo FJ, Núñez de Castro I, et al. 1994. Phosphate-activated glutaminase expression during tumor development. FEBS Lett 341:39-42.
8. Curthoys NP, Watdford M. 1995. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15:133-159.
9. Quesada AR, Medina MA, Márquez J, Sánchez-Jiménez F, Núñez de Castro I. 1998. Contribution by host tissues to circulating glutamine in mice inoculated with Ehrlich ascitic tumor cells. Cancer Res 48:1551-1553.
10. Márquez J, Sánchez-Jiménez F, Medina MA, Quesada AR, Núñez de Castro I. 1989. Nitrogen metabolism in tumor bearing mice. Arch Biochem Biophys 268:667-675.
11. Márquez J, Núñez de Castro I. 1991. Mouse liver free amino acids during the development of Ehrlich ascites tumour. Cancer Lett 58:221-224.
12. Battaglia FC. 2000. Glutamine and glutamate exchange between the fetal liver and the placenta. J Nutr 130:974S-977S.
13. Collins CL, Wasa M, Souba WW, Abcouwer SF. 1998. Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell line. J Cell Physiol 176:166-178.
14. Medina MA. 2001. Glutamine and cancer. J Nutr 131:2539S-2542S.
15. Souba WW. 1993. Glutamine and cancer. Ann Surg 218:715-728.
16. Sebol JS, Weber G. 1984. Negative correlations of L-glutamine concentration with proliferation rate in rat hepatomas. Life Sci 34:301-306.
17. Spittler A, Oehler R, Goetzinger P, Holzer S, Reissner CM, et al. 1997. Low glutamine concentrations induce phenotypical and functional differentiation of U937 myelomonocytic cells. J Nutr 127:2151-2157.
18. Turowski GA, Rashid Z, Hong F, Madri JA, Basson MD. 1994. Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Cancer Res 54:5974-5980.
19. Lobo C, Ruíz-Bellido MA, Aledo JC, Márquez J, Núñez de Castro I, et al. 2000. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 348: 257-261.
20. Bode BP, Souba WW. 1999. Glutamine transport and human hepatocellular transformation. J Parenter Enteral Nutr 23:S33-S37.
21. Bode BP. 2001. Recent molecular advances in mammalian glutamine transport. J Nutr 131:2475S-2485S
22. McGivan JD. 1998. Rat hepatoma cells express novel transport system for glutamine and glutamate to those present in normal rat hepatocytes. Biochem J 330:255-260.
23. Bode BP, Fuchs BC, Hurley BP, Conroy JL, Suetterlin JE, et al. 2002. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol 283:G1062-G1073.
24. Dolinska M, Dybel A, Zablocka B, Albrecht J. 2003. Glutamine transport in C6 glioma cells shows ASCT2 system characteristics. Neurochem Int 43:501-507.
25. Witte D, Ali N, Carlson N, Younes M. 2002. Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res 22:2555-2557.
26. Wasa M, Wang HS, Okada A. 2002. Characterization of L-glutamine transport by a human neuroblastoma cell line. Am J Physiol 282:C1246-C1253.
27. Hara K, Kudoh H, Enomoto T, Hashimoto Y, Masuko T. 1999. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem Biophys Res Commun 262:720-725.
28. Yagita H, Masuko T, Hashimoto Y. 1986. Inhibition of tumor cell growth in vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and human. Cancer Res 46:1478-1484.
29. Nikolova M, Guenova M, Taskov H, Dimitrova E, Staneva M. 1998. Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia. Leuk Res 22:39-47.
30. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, et al. 2001. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochem Biophys Acta 1514:291-302.
31. Wolf DA, Wang S, Panzica MA, Bassily NH, Thompson NL. 1996. Expression of a highly conserved oncofetal gene, TA1/E16, in human colon carcinoma and other primary cancers: homology to Schistosoma mansoni amino acid permease and Caenorhabditis elegans gene products. Cancer Res 56:5012-5022.
32. Sang J, Lim YP, Panzica M, Finch P, Thompson NL. 1995. TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation. Cancer Res 55:1152-1159.
33. nd ed. New York: Wilely. p 464-470.
34. Ye ZC, Sontheimer H. 1999. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383-4391.
35. Takano T, Lin JHC, Arcuino G, Gao Q, Yang J, et al. 2001. Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015.
36. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med 8:971-978.
37. Ye ZC, Rothstein JD, Sontheimer H. 1999. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci 19:10767-10777.
38. Bannai S, Ishii T. 1988. A novel function of glutamine in cell culture: utilization of glutamine for the uptake of cystine in human fibroblasts. J Cell Physiol 137:360-366.
39. Sato H, Tamba M, Ishii T, Bannai S. 1999. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274:11455-11458.
40. Bannai S. 1986. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261:2256-2263.
41. Guo H, Lai L, Butchbach MER, Lin CLG. 2002. Human glioma cells and undifferentiated primary astrocytes that express aberrant EAAT2 mRNA inhibit normal EAAT2 protein expression and prevent cell death. Mol Cell Neurosci 21:546-560.
42. Mordrelle A, Jullian E, Costa C, Corment-Boyaka E, Benamouzig R, et al. 2000. EAAT1 is involved in transport of L-glutamate during differentiation of the Caco-2 cell line. Am J Physiol 279:G366-G373.
43. Pollard M, McGivan JD. 2000. The rat hepatoma cell line H4-II-E-C3 express high activities of the high-affinity glutamate transporter GLT-1A. FEBS Lett 484:74-76.
44. Rossi DJ, Oshima T, Attwell D, 2000. Glutamate release in severe ishaemia is mainly by reversed uptake. Nature 403:316-321.
45. Wonderlin WF, Woodfork KA, Strobl JS. 1995. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 165:177-185.
46. Marino AA, Iliev IG, Schwalke MA, Gonzalez E, Marier KC, et al. 1994. Association between cell membrane potential and breast cancer. Tumor Biol 15:82-89.
47. Cuzick J, Holland R, Barth V, Davies R, Faupel M, et al. 1998. Electropotential measurements as a new diagnostic modality for breast cancer. Lancet 352:359-363.
48. Makowske M, Christensen HN. 1982. Contrast in transport systems for anionic amino acids in hepatocytes and hepatoma cell line HTC. J Biol Chem 257:5663-5670.
49. +-requiring transport system for alanine, serine, cysteine, and similar amino acids. J Biol Chem 242:5237-5246.
50. Vadgama JV, Christensen HN. 1984. Wide distribution of pH-dependent service of transport system ASC for both anionic and zwitterionic amino acids. J Biol Chem 259:3648-3652.
51. +-dependent neutral amino acid transporter. J Biol Chem 271:14883-14890.
52. Munck BG, Munck LK. 1999. Effects of pH changes on systems ASC and B in rabbit ileum. Am J Physiol 276:G173-G184.
53. Webb SD, Sherratt JA, Fish RG. 1999. Mathematical modelling of tumour acidity: regulation of intracellular pH. J theor Biol 196:237-250.
54. Tetsuka K, Takanaga H, Ohtsuki S, Hosoya K, Terasaki T. 2003. The L-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier. J Neurochem 87:891-901.
55. Bannai S, Ishii T. 1982. Transport of cystine and cysteine and cell growth in culture human diploid fibroblasts: effect of glutamate and homocysteate. J Cell Physiol 112:265-272.
56. Matés JM, Pérez-Gómez C, Núñez de Castro I, Asenjo M, Márquez J. 2002. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 34:439-458.
57. Okuno S, Sato H, Kuriyama-Matsumura K, Tamba M, Wang H, et al. 2003. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Brit J Cancer 88:951-956.
58. +-ATPase: mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-C311.
59. Buttgereit F, Brand MD. 1995. A hierarchy of ATP-consuming processes in mammalian cells. Biochem J 312:163-167.
60. García-Sancho J, Sánchez A, Handlogten ME, Christensen HN. 1977. Unexpected additional mode of energetization of amino-acid transport into Ehrlich cells. Proc Natl Acad Sci USA 74:1488-1491.
61. Medina MA, Núñez de Castro I. 1990. Plasma membrane oxidoreduction and amino acid transport. In: Crane FL, Morré DJ, Löw HE, editors. Oxidoreduction at the plasma membrane: relation to growth and transport. Boca Raton: CRS Press. p. 247-255.
62. Aledo JC, de Pedro E, Gómez-Fabre PM, Núñez de Castro I, Márquez J. 2000. Changes in mRNAs for enzymes of glutamine metabolism in the tumor-bearing mouse. Anticancer Res 20:1463-1466.
63. de Graaf-Hess A, Trijbels F, Blom H. 1999. New method for determining cystine in leukocytes and fibroblasts. Clin Chem 45:2224-2228.
64. Hidelbrandt W, Kinscherf R, Hauer K, Holm E, Dröge W. 2002. Plasma cystine concentration and redox state in aging and physical exercise. Mech Ageing Dev 123:1269-1281.
65. Aledo JC, Esteban del Valle A. 2002. Glycolysis in wonderland: the importance of energy dissipation in metabolic pathways. J Chem Educ 79:1336-1339.
66. Aledo JC. 2001. Metabolic pathways: does the actual Gibbs free-energy change affect the flux rate? Biochem Mol Biol Educ 29:142-143.
67. Westerhoff HV, Hellingwerf KJ, van Dam K. 1982. Thermodynamic efficiency of microbial growth is low but optimal for maximal growth rate. Proc Natl Acad Sci USA 80:305-309.
68. Mathews CK, van Holde KE, Ahern KG. 2002. Biochemistry, 3rd ed. San Francisco: Addison Wesley Longman. p. 463-498.
69. Newsholme EA, Crabtree B, Ardawi MS. 1985. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 70:473-489.
70. Newsholme EA, Board M. 1991. Application of metabolic-control logic to fuel utilization and its significance in tumor cells. Adv Enzyme Regul 31:225-246.
71. Newsholme P, Curi R, Pithon-Curi TC, Murphy CJ, Garcia C, et al. 1999. Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease. J Nutr Biochem 10:316-324.